• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对于通过纳米沉淀法制备的聚(丙交酯-乙交酯)纳米颗粒,溶剂的选择会导致“茴香酒区域”发生显著偏移。

Solvent selection causes remarkable shifts of the "Ouzo region" for poly(lactide-co-glycolide) nanoparticles prepared by nanoprecipitation.

作者信息

Beck-Broichsitter Moritz, Nicolas Julien, Couvreur Patrick

机构信息

Institut Galien Paris-Sud, CNRS UMR 8612, University of Paris-Sud, F-92196, Châtenay-Malabry Cedex, France.

出版信息

Nanoscale. 2015;7(20):9215-21. doi: 10.1039/c5nr01695a. Epub 2015 Apr 30.

DOI:10.1039/c5nr01695a
PMID:25924854
Abstract

Polymer nanoparticles (NPs) offer versatile novel biological features of interest for drug delivery applications. "Ouzo diagrams" allowed for a systematic manufacture of specified colloidal formulations by the widely used nanoprecipitation process. Surprisingly, despite the well-documented relevance of the applied organic solvent for nanoprecipitation, its effect on the actual status of the "Ouzo region" was so far not studied. Herein, investigations were undertaken to account for the potential impact of the solvent type on the "Ouzo diagrams" for poly(lactide-co-glycolide) (PLGA) and tetrahydrofuran (THF), 1,4-dioxane, acetone and dimethyl sulfoxide (DMSO). The "Ouzo region" shifted considerably to higher polymer fractions upon solvent change (rank order: THF < 1,4-dioxane < acetone < DMSO). Assuming a one-to-one transformation of detached PLGA-bearing solvent droplets (droplet diameter for THF: ∼800 nm, 1,4-dioxane: ∼700 nm, acetone: ∼500 nm and DMSO: ∼300 nm) into non-divisible polymer aggregates upon solvent displacement, facilitated to predict the size of NPs found within the "Ouzo region" (size range: 40-200 nm). In conclusion, application of "Ouzo diagrams" is a valuable tool for drug delivery research and will most-likely replace the "trial-and-error"-approach to identify the operating window for the production of stable colloidal formulations by the nanoprecipitation technique.

摘要

聚合物纳米颗粒(NPs)具有多种新颖的生物学特性,在药物递送应用中具有重要意义。“乌佐图”通过广泛使用的纳米沉淀法实现了特定胶体配方的系统制备。令人惊讶的是,尽管有机溶剂在纳米沉淀中的作用已有充分记录,但迄今为止尚未研究其对“乌佐区域”实际状态的影响。在此,我们进行了研究,以探讨溶剂类型对聚(丙交酯 - 乙交酯)(PLGA)与四氢呋喃(THF)、1,4 - 二氧六环、丙酮和二甲基亚砜(DMSO)形成的“乌佐图”的潜在影响。随着溶剂的变化,“乌佐区域”显著向更高的聚合物分数偏移(排序为:THF < 1,4 - 二氧六环 < 丙酮 < DMSO)。假设在溶剂置换后,带有PLGA的分离溶剂液滴(THF的液滴直径约为800 nm,1,4 - 二氧六环约为700 nm,丙酮约为500 nm,DMSO约为300 nm)一对一转化为不可分割的聚合物聚集体,这有助于预测在“乌佐区域”内发现的纳米颗粒的大小(尺寸范围:40 - 200 nm)。总之,“乌佐图”的应用是药物递送研究的一个有价值的工具,很可能会取代“试错”方法,以确定通过纳米沉淀技术生产稳定胶体配方的操作窗口。

相似文献

1
Solvent selection causes remarkable shifts of the "Ouzo region" for poly(lactide-co-glycolide) nanoparticles prepared by nanoprecipitation.对于通过纳米沉淀法制备的聚(丙交酯-乙交酯)纳米颗粒,溶剂的选择会导致“茴香酒区域”发生显著偏移。
Nanoscale. 2015;7(20):9215-21. doi: 10.1039/c5nr01695a. Epub 2015 Apr 30.
2
Stability-limit "Ouzo region" boundaries for poly(lactide-co-glycolide) nanoparticles prepared by nanoprecipitation.通过纳米沉淀法制备的聚(丙交酯-乙交酯)纳米颗粒的稳定性极限“茴香酒区域”边界
Int J Pharm. 2016 Sep 10;511(1):262-266. doi: 10.1016/j.ijpharm.2016.07.010. Epub 2016 Jul 11.
3
Preparation of nanoparticles by solvent displacement for drug delivery: a shift in the "ouzo region" upon drug loading.溶剂置换法制备载药纳米粒子:载药后“ouzo 区域”的转变。
Eur J Pharm Sci. 2010 Oct 9;41(2):244-53. doi: 10.1016/j.ejps.2010.06.007. Epub 2010 Jun 22.
4
Small angle neutron scattering studies on the internal structure of poly(lactide-co-glycolide)-block-poly(ethylene glycol) nanoparticles as drug delivery vehicles.聚(丙交酯-乙交酯)-嵌段-聚乙二醇纳米颗粒作为药物递送载体的内部结构的小角中子散射研究
Biomacromolecules. 2015 Feb 9;16(2):457-64. doi: 10.1021/bm501519u. Epub 2015 Jan 14.
5
Nanoparticles obtained by confined impinging jet mixer: poly(lactide-co-glycolide) vs. Poly-ε-caprolactone.限域撞击射流混合器制得的纳米粒子:聚(丙交酯-共-乙交酯)与聚己内酯的对比。
Drug Dev Ind Pharm. 2018 Jun;44(6):934-941. doi: 10.1080/03639045.2017.1421662. Epub 2018 Jan 9.
6
Using the polymeric ouzo effect for the preparation of polysaccharide-based nanoparticles.利用聚合物奥佐效应制备多糖基纳米颗粒。
Langmuir. 2013 Jul 16;29(28):8845-55. doi: 10.1021/la4017867. Epub 2013 Jul 2.
7
Nanoprecipitation of polymethylmethacrylate by solvent shifting: 1. Boundaries.
Langmuir. 2009 Feb 17;25(4):1970-9. doi: 10.1021/la803000e.
8
Non-aggregated protamine-coated poly(lactide-co-glycolide) nanoparticles of cisplatin crossed blood-brain barrier, enhanced drug delivery and improved therapeutic index in glioblastoma cells: in vitro studies.顺铂的非聚集鱼精蛋白包被聚(丙交酯-共-乙交酯)纳米颗粒可穿过血脑屏障,增强药物递送并改善胶质母细胞瘤细胞的治疗指数:体外研究。
J Microencapsul. 2014;31(7):685-93. doi: 10.3109/02652048.2014.913725. Epub 2014 Jun 25.
9
Stability of exenatide in poly(D,L-lactide-co-glycolide) solutions: a simplified investigation on the peptide degradation by the polymer.艾塞那肽在聚(D,L-丙交酯-共-乙交酯)溶液中的稳定性:通过聚合物对肽降解的简化研究。
Eur J Pharm Sci. 2013 Nov 20;50(3-4):502-10. doi: 10.1016/j.ejps.2013.08.014. Epub 2013 Aug 29.
10
Nanoprecipitation and the "Ouzo effect": Application to drug delivery devices.纳米沉淀法和“茴香酒效应”:在药物输送装置中的应用。
Adv Drug Deliv Rev. 2014 May;71:86-97. doi: 10.1016/j.addr.2013.12.009. Epub 2013 Dec 30.

引用本文的文献

1
Nano-engineering nanomedicines with customized functions for tumor treatment applications.纳米工程纳米药物,赋予其针对肿瘤治疗应用的定制功能。
J Nanobiotechnology. 2023 Aug 2;21(1):250. doi: 10.1186/s12951-023-01975-3.
2
Sustainability in Drug and Nanoparticle Processing.药物与纳米颗粒加工中的可持续性。
Handb Exp Pharmacol. 2024;284:45-68. doi: 10.1007/164_2023_659.
3
Mucoadhesive PLGA Nanospheres and Nanocapsules for Lactoferrin Controlled Ocular Delivery.用于乳铁蛋白眼部控释给药的黏膜黏附性聚乳酸-羟基乙酸共聚物纳米球和纳米囊
Pharmaceutics. 2022 Apr 6;14(4):799. doi: 10.3390/pharmaceutics14040799.
4
Recent Advances in the Surface Functionalization of PLGA-Based Nanomedicines.基于聚乳酸-羟基乙酸共聚物的纳米药物表面功能化的最新进展
Nanomaterials (Basel). 2022 Jan 22;12(3):354. doi: 10.3390/nano12030354.
5
Effect of Crystallinity on the Properties of Polycaprolactone Nanoparticles Containing the Dual FLAP/mPEGS-1 Inhibitor BRP-187.结晶度对含有双FLAP/mPEGS-1抑制剂BRP-187的聚己内酯纳米颗粒性能的影响。
Polymers (Basel). 2021 Jul 31;13(15):2557. doi: 10.3390/polym13152557.
6
Formulation of Liver-Specific PLGA-DY-635 Nanoparticles Loaded with the Protein Kinase C Inhibitor Bisindolylmaleimide I.负载蛋白激酶C抑制剂双吲哚马来酰胺I的肝脏特异性聚乳酸-羟基乙酸共聚物-DY-635纳米颗粒的制剂
Pharmaceutics. 2020 Nov 18;12(11):1110. doi: 10.3390/pharmaceutics12111110.
7
Finding key nanoprecipitation variables for achieving uniform polymeric nanoparticles using neurofuzzy logic technology.利用神经模糊逻辑技术找到实现聚合物纳米粒子均匀性的关键纳米沉淀变量。
Drug Deliv Transl Res. 2018 Dec;8(6):1797-1806. doi: 10.1007/s13346-017-0446-8.
8
Preparation of Drug-Loaded PLGA-PEG Nanoparticles by Membrane-Assisted Nanoprecipitation.通过膜辅助相分离法制备载药 PLGA-PEG 纳米粒。
Pharm Res. 2017 Jun;34(6):1296-1308. doi: 10.1007/s11095-017-2146-y. Epub 2017 Mar 24.
9
Drug-Initiated Synthesis of Polymer Prodrugs: Combining Simplicity and Efficacy in Drug Delivery.药物引发的聚合物前药合成:在药物递送中兼具简便性与有效性
Chem Mater. 2016 Mar 22;28(6):1591-1606. doi: 10.1021/acs.chemmater.5b04281. Epub 2016 Feb 21.